Compound_ID |
Target |
Gene_Name |
Gene_ID |
Cancer |
Cell_lines |
IC50 Value |
EC50 Value |
ED50 Value |
GI50 Value |
Remarks |
References |
MMP-AC0099 |
ALPP |
alkaline phosphatase, placental |
250 |
Human Carcinoma |
CeHa |
- |
- |
- |
- |
Elevated levels of serum alkaline phosphatase (ALP) in the N- nitrosodiethylamine administered group were significantly reduced by Emblica officinalis (E. officinalis) polyphenol fraction (EOP) treatment. |
12866570 |
MMP-AC0099 |
ALPP |
alkaline phosphatase, placental |
250 |
Dalton'sLymphoma Ascites (DLA) |
- |
- |
- |
- |
- |
Elevated levels of serum alkaline phosphatase (ALP) in the N- nitrosodiethylamine administered group were significantly reduced by Emblica officinalis (E. officinalis) polyphenol fraction (EOP) treatment. |
12866570 |
MMP-AC0099 |
CDC25C |
cell division cycle 25 homolog C (S. pombe) |
995 |
Human Carcinoma |
CeHa |
15 µg/mL. |
- |
- |
- |
Emblica officinalis (E. officinalis) polyphenol fraction (EOP) inhibited the activity of cdc25 tyrosine phosphatase, an important enzyme involved in cell cycle regulation. This enzyme is a critical regulator of M phase promoting factor (MPF), which removes inhibitory phosphates in the catalytic domain of p34cdc2 thereby directly controls the entry of cells into M phase. |
12866570 |
MMP-AC0099 |
CDC25C |
cell division cycle 25 homolog C (S. pombe) |
995 |
Dalton'sLymphoma Ascites (DLA) |
- |
15 µg/ml |
- |
- |
- |
Emblica officinalis (E. officinalis) polyphenol fraction (EOP) inhibited the activity of cdc25 tyrosine phosphatase, an important enzyme involved in cell cycle regulation. This enzyme is a critical regulator of M phase promoting factor (MPF), which removes inhibitory phosphates in the catalytic domain of p34cdc2 thereby directly controls the entry of cells into M phase. |
12866570 |
MMP-AC0099 |
GGT1 |
gamma-glutamyltransferase 1 |
2678 |
Human Carcinoma |
CeHa |
- |
- |
- |
- |
Gamma-glutamyl transpeptidase activity was raised to 88.4 ± 16.2 U/l in serum of N- nitrosodiethylamine treated group was reduced to 48.4 ± 14.8 U/l by Emblica officinalis (E. officinalis) polyphenol fraction (EOP) treatment. |
12866570 |
MMP-AC0099 |
GGT1 |
gamma-glutamyltransferase 1 |
2678 |
Dalton'sLymphoma Ascites (DLA) |
- |
- |
- |
- |
- |
Gamma-glutamyl transpeptidase activity was raised to 88.4 ± 16.2 U/l in serum of N- nitrosodiethylamine treated group was reduced to 48.4 ± 14.8 U/l by Emblica officinalis (E. officinalis) polyphenol fraction (EOP) treatment. |
12866570 |
MMP-AC0099 |
GPT |
glutamic-pyruvate transaminase (alanine aminotransferase) |
2875 |
Human Carcinoma |
CeHa |
- |
- |
- |
- |
Elevated levels of serum glutamate pyruvate transaminase (GPT), in the N- nitrosodiethylamine administered group were significantly reduced by Emblica officinalis (E. officinalis) polyphenol fraction (EOP) treatment. |
12866570 |
MMP-AC0099 |
GPT |
glutamic-pyruvate transaminase (alanine aminotransferase) |
2875 |
Dalton'sLymphoma Ascites (DLA) |
- |
- |
- |
- |
- |
Elevated levels of serum glutamate pyruvate transaminase (GPT), in the NDEA administered group were significantly reduced by Emblica officinalis (E. officinalis) polyphenol fraction (EOP) treatment. |
12866570 |
MMP-AC0099 |
STM1 |
glutathione S-transferase mu 1 |
2944 |
Dalton'sLymphoma Ascites (DLA) |
- |
- |
- |
- |
- |
Elevated levels of liver glutathione S- transferase (GST) level in the N- nitrosodiethylamine administered group were significantly reduced by Emblica officinalis (E. officinalis) polyphenol fraction (EOP) treatment. |
12866570 |
MMP-AC0099 |
GSTM1 |
glutathione S-transferase mu 1 |
2944 |
Human Carcinoma |
CeHa |
- |
- |
- |
- |
Elevated levels of liver glutathione S- transferase (GST) level in the N- nitrosodiethylamine administered group were significantly reduced by Emblica officinalis (E. officinalis) polyphenol fraction (EOP) treatment. |
12866570 |
MMP-AC0099 |
TOP2A |
topoisomerase (DNA) II alpha 170kDa |
7153 |
Human Carcinoma |
CeHa |
- |
- |
- |
- |
Emblica officinalis (E. officinalis) polyphenol fraction (EOP) was found to inhibit the activity of topoisomerase II in Sacchromyces cerviacae mutant cell cultures. Cancer cells have higher topoisomerase II levels. Therefore, inhibition of this enzyme is a likely target for therapeutic intervention and may suppress cell proliferation. |
12866570 |
MMP-AC0099 |
TOP2A |
topoisomerase (DNA) II alpha 170kDa |
7153 |
Dalton'sLymphoma Ascites (DLA) |
- |
- |
- |
- |
- |
Emblica officinalis (E. officinalis) polyphenol fraction (EOP) was found to inhibit the activity of topoisomerase II in Sacchromyces cerviacae mutant cell cultures. Cancer cells have higher topoisomerase II levels. Therefore, inhibition of this enzyme is a likely target for therapeutic intervention and may suppress cell proliferation. |
12866570 |